Sign in

NCT04810858Recruiting

Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury

Source: ClinicalTrials.gov · Last updated 31 Mar 2026

Brief summary (registry, in English)

This study applies a hypothesis-driven approach to examine the effects of chronic marijuana use on HIV-associated inflammation and its subsequent impacts on central nervous system function, with the goal of identifying the mechanisms through which cannabinoids modulate neurological disorders and other comorbidities in persons with HIV.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
220 (estimated)
First submitted
16 Mar 2021
Start date
18 Aug 2021
Primary completion date
31 May 2027
Lead sponsor
Wake Forest University Health Sciences
Diseases
HIV
NCT number
NCT04810858

What you commit to

  • Study type: Interventional
  • Planned participants: 220
  • From 18 Aug 2021 to the primary completion date, 31 May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Lifetime abuse for any illicit drug other than marijuana
  • immunotherapy

Other illness

  • history of moderate or severe head trauma
  • unstable or serious neurological disorders
  • severe mental illness
  • systemic autoimmune diseases

Other

  • \<9th grade education; illiteracy or lack of fluency in English
  • MRI contraindications

Who the study is looking for

  • verified HIV status
  • Current marijuana use (MJ+ groups only)
  • No current marijuana use (MJ- groups only)
  • current engagement in HIV care (HIV+ participants only)
  • receipt of cART as first-line of treatment (HIV+ participants only)
  • stable cART regimen (HIV+ participants only)
  • undetectable HIV RNA viral load for \>1 year (HIV+ participants only)

Age in the registry: 25 years to 59 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Biotech Place
Coordinator of this site? Confirm its status
Winston-SalemUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.